Study analyzes cost-effectiveness of screenings for nasopharyngeal carcinoma in adults in southern China.
Evidence of COVID-19 Impacts on Rectal Cancer Treatment
Fewer patients are eligible for sphincter-preserving surgery during pandemic.
Cohorts Worth Screening After Definitive Head and Neck Squamous Cell Carcinoma Treatment
Cleveland Clinic researchers identify specific cohorts of head and neck squamous cell carcinoma patients at increased risk of distant failure who may benefit most from surveillance imaging.
A Pandemic of Cancer Cases?
A sharp upswing in cancer diagnoses, harder-to-treat advanced cancers, and cancer deaths may be among the many unexpected consequences of the coronavirus pandemic, Cleveland Clinic Cancer Center oncologist Mikkael Sekeres, MD, warns in a new New York Times column.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Cancer Program on the Rise at Cleveland Clinic Abu Dhabi
Cleveland Clinic Abu Dhabi’s Oncology Institute, which will occupy a new state-of-the-art cancer center currently construction, aims to transform cancer care in the Middle East, using Cleveland Clinic Cancer Center as its model.
New Blood Test Detects Multiple Cancer Types with High Accuracy
A prototype blood-based screening test evaluated by Cleveland Clinic researchers and others can accurately detect and localize multiple types of cancer, often before symptoms show. The promising results raise hopes that the assay will help achieve the long-sought goal of population-scale early detection of cancer.
Prostate Cancer Pearls for Primary Care Physicians
Primary care physicians play a vital role in detecting cancers at earlier stages. Prostate cancer is the most common cancer in the U.S., and screening is still controversial.
How Do Older Adults Feel About Forgoing Cancer Screenings?
JAMA Internal Medicine, recently released results of a study on the topic of “Older adults’ views and communication preferences about cancer screening cessation.” Ronan Factora, MD, of Cleveland Clinic’s Center for Geriatric Medicine, weighs in on study findings.
New Survey Finds Colorectal Cancer Screening Underutilized
Carol Burke, MD, and Co-investigator David Dornblaser, MS, share their findings with other physicians and digestive specialists at DDW 2017.
Trainees Struggle To Recall Colorectal Cancer Guidelines
A recent survey of trainee colonoscopists and their primary care peers showed they have poor recollection of colorectal cancer screening and surveillance guidelines, despite having recently studied them.